DGAP-News: Raptor Pharmaceutical Corp.

DGAP-News: Raptor Pharmaceutical Corp. to Present at Three Upcoming Investor Conferences

Raptor Pharmaceutical Corp.

10.02.2012 12:30 ---------------------------------------------------------------------------

NOVATO, Calif., 2012-02-10 12:30 CET (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ('Raptor' or the 'Company') (Nasdaq:RPTP) today announced that its Chief Executive Officer, Christopher M. Starr, Ph.D., will present an overview of the Company at three investor conferences in February.

The conference presentation schedule is as follows:

Leerink Swann 2012 Global Healthcare Conference February 16, 2012 at 3:30pm ET The Waldorf Astoria, New York, NY Citi 2012 Global Healthcare Conference February 27, 2012 at 2:00pm ET The Waldorf Astoria, New York, NY 2012 RBC Capital Markets' Global Healthcare Conference February 28, 2012 at 4:35pm ET The Palace Hotel, New York, NY

A live audio webcast and 14-day archive of the Citi and RBC presentations will be available at http://ir.raptorpharma.com/events.cfm

About Raptor Pharmaceutical Corp.

Raptor Pharmaceutical Corp. (Nasdaq:RPTP) ('Raptor') seeks to research, produce, and deliver medicines that improve life for patients with severe, rare disorders. Raptor currently has product candidates in clinical development designed to potentially treat nephropathic cystinosis, Non-alcoholic Steatohepatitis ('NASH'), Huntington's Disease ('HD'), aldehyde dehydrogenase deficiency ('ALDH2'), and thrombotic disorder.

Raptor's preclinical programs are based upon bioengineered novel drug candidates and drug-targeting platforms derived from the human receptor-associated protein and related proteins that are designed to target cancer and infectious diseases.

For additional information, please visit www.raptorpharma.com.

The Raptor Pharmaceutical Corp. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7180

CONTACT: Trout Group (investors) Lauren Glaser (646) 378-2972 lglaser@troutgroup.com EVC Group (media) Janine McCargo (646) 688-0425 jmccargo@evcgroup.com News Source: Nasdaq OMX



10.02.2012 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de

--------------------------------------------------------------------------- Language: English Company: Raptor Pharmaceutical Corp. United States Phone: Fax: E-mail: Internet: ISIN: US75382F1066 WKN: End of Announcement DGAP News-Service ---------------------------------------------------------------------------